. . . from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000069059:Atorvastatin; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D011758:Pyrroles / Q000627:therapeutic use; D012206:Rhabdomyolysis / Q000139:chemically induced
D019380:Anti-HIV Agents; D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin